U.S. House Of Representatives Passes Global Health Innovation Act

Office of Congressman Albio Sires: Congressman Sires’ Global Health Resolution Passes House of Representatives
“…Specifically, H.R. 1660 will provide the oversight needed to gain a clearer picture of the United States Agency for International Development’s (USAID) global health research and development. Over the years, research and development projects have greatly expanded at USAID, searching for advancements towards an HIV- and AIDS-free generation, preventable maternal and childhood deaths, and preventable infectious diseases. H.R. 1660 directs the USAID administrator to report to Congress on the development and use of global health innovations in USAID programs, projects, and activities, ensuring that taxpayer dollars are being spent in the most efficient and effective ways possible…” (1/19).

Global Health Technologies Coalition: GHTC welcomes House passage of the Global Health Innovation Act
“The Global Health Technologies Coalition (GHTC) welcomes [Thursday’s] passage by the U.S. House of Representatives of the Global Health Innovation Act (H.R. 1660), a bipartisan bill that will strengthen efforts by the U.S. Agency for International Development (USAID) to develop lifesaving drugs, vaccines, and other health technologies for people in need around the world…” (1/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.